DNA Microarray Market Growth and Size, Rising Trends, Analysis, CAGR Status, Challenges and Future Opportunities and Forecast 2034
A DNA microarray is a powerful tool in the laboratory that may be used to simultaneously analyze the expression of thousands of genes. DNA probes are systematically arranged on a small, solid surface, usually a glass slide or a silicon chip. The tiny DNA strands that make up these probes can bind to complementary sequences in a sample. The sample, usually RNA that has been converted to complementary DNA (cDNA), is identified using fluorescent markers prior to being placed on the microarray. To measure the levels of gene expression, one can observe the fluorescence that arises when the cDNA binds to the proper probes on the array.
According to SPER market research, ‘DNA Microarray Market Size- By Source, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the DNA Microarray Market is predicted to reach 5.11 billion by 2034 with a CAGR of 9.09%.
Drivers: The growing incidence of cancer, information technology breakthroughs, and the development of bioinformatics are all anticipated to contribute to the growth of the global market. With advancements in array design and bioinformatics, DNA microarrays—which are frequently employed in gene expression studies and research—continue to change. DNA microarrays are still useful because of their low cost, simplicity of use, and well-established techniques, even if technologies like RNA sequencing provide better resolution and sensitivity. They play a key role in areas such as personalized medicine, molecular diagnostics, and genomics. Furthermore, precision medicine and genomic research are being advanced by strategic partnerships like the one between Thermo Fisher Scientific and the Qatar Genome Program.
Restraints: However, the market faces obstacles such competition from next-generation sequencing (NGS) technologies, which provide precise and affordable alternatives to DNA microarrays. The high cost of microarray technology, stringent regulatory frameworks, issues with standardization, and a shortage of skilled workers are additional barriers to growth.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/dna-microarray-market.aspx?sample=1
In 2024, North America accounted for the majority of revenue in the DNA microarray market due to the presence of important industry players and their enhanced efforts to develop better DNA microarray products. Access to state-of-the-art research facilities and genomic developments are expected to create significant development opportunities. Some significant market players are Agilent Technologies, Applied Micro Arrays, BIOMERIEUX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN, Thermo Fisher Scientific, Inc., and others.
DNA Microarray Market Segmentation:
By Type: Based on the Type, Global DNA Microarray Market is segmented as; Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Others.
By Application: Based on the Application, Global DNA Microarray Market is segmented as; Gene Expression Analysis, Genotyping, Others.
By End Use: Based on the End Use, Global DNA Microarray Market is segmented as; Gene Expression Analysis, Genotyping, Others.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.
For More Information, refer to below link: -
Related Reports:
Contact Us:?
Sara Lopes, Business Consultant — USA?
+1–347–460–2899
?